CRS insiders

16 insiders have filed at CRS since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Thene Tony RPresident And CEO540.5k1.075%5 sells $9.8M
Karol Steven EDirector402.4k0.8%11 sells $16.4M
Lain TimothySVP And CFO109.4k0.218%1 sells $595k
Malloy Brian JPresident And COO78.9k0.157%21 sells $23.6M
Dee James DSVP, Gen Counsel & Sec73.7k0.147%5 sells $10.0M
Haniford Joseph ESVP Continuous Improvement60.5k0.12%
Akins Marshall DVP And Chief Comm Officer30.2k0.06%2 sells $543k
Ward JR Stephen MDirector26.3k0.052%
Graf DavidVP & Group President Pep25.6k0.051%
Socci Elizabeth AVP, Contr & Ch Acctg Officer9.1k0.018%7 sells $2.3M
Inglis I MartinDirector6.7k0.013%3 sells $2.2M
Mclane Charles Douglas JRDirector6.5k0.013%1 sells $252k
Younessi RaminDirector1.9k<0.01%4 sells $993k
Acoff Viola LDirector1 sells $807k
Hart Anastasios JohnDirector1 sells $244k
Pritchett ColleenDirector1 sells $280k

Full register at boothcheck.com/insiders/CRS. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

CRS institutional holders · CRS research report